(28 days)
No
The description focuses on signal acquisition, processing, and display with an "automated software waveform detector" and "menu-driven software" for analysis, which are standard digital signal processing and software functionalities, not indicative of AI/ML. There is no mention of learning, adaptation, or complex pattern recognition beyond basic waveform detection and interval measurement.
No.
The device is used for diagnostic purposes during electrophysiology procedures, such as measuring electrical conduction and mapping arrhythmias, rather than for directly treating a condition.
Yes
The "Intended Use / Indications for Use" section explicitly states that the system is "intended to be used for diagnostic electrical stimulation of the heart for the purpose of refractory measurements, initiation and termination of tachy-arrhythmias, measurements of electrical conduction, and arrhythmia mapping."
No
The device description explicitly lists multiple hardware components including a computer, monitors, amplifier, junction box, and printer, in addition to the software.
Based on the provided information, the EP-WorkMate™ System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- EP-WorkMate Function: The EP-WorkMate System directly interacts with the patient's heart during a clinical electrophysiology procedure. It acquires and analyzes electrical signals from within the body (intracardiac) and from the body surface (ECG). It does not analyze specimens taken from the body.
- Intended Use: The intended use clearly states it's for use during clinical electrophysiology procedures for diagnostic electrical stimulation and recording of electrical signals from the heart.
Therefore, the EP-WorkMate System is a medical device used for in-vivo (within the living body) diagnostic and monitoring purposes, not an in-vitro diagnostic device.
N/A
Intended Use / Indications for Use
The EP-WorkMate™ System is indicated for use during clinical electrophysiology procedures.
The EP-WorkMate® system with an EP-4 stimulator is intended to be used for diagnostic electrical stimulation of the heart for the purpose of refractory measurements, initiation and termination of tachy-arrhythmias, measurements of electrical conduction, and arrhythmia mapping.
Product codes (comma separated list FDA assigned to the subject device)
DQK
Device Description
The EP-WorkMate system is a computer-based electrophysiological recording and monitoring system that is used to capture, display, store, and retrieve surface and intracardiac electrical signals during electrophysiology studies. It consists of a computer. two 21" high-resolution monitors, a multi-channel signal amplifier and filtering system (signal conditioning unit), a catheter junction box, and a laser printer. The system may also be configured with an integrated EP-4 clinical stimulator and touch-screen computer monitor (cleared in K040207).
The EP-WorkMate is connected to electrophysiology catheters that are guided into various locations within the heart, and to surface electrocardiogram (ECG) cables. Intracardiac and ECG signals are then acquired from electrodes on the indwelling catheters and ECG leads, and transmitted to the amplifier, which amplifies and conditions the signals before they are received by the EP-WorkMate computer for measurement and display.
During the procedure, cardiac signals are acquired and an automated software waveform detector (trigger) performs online recognition of cardiac activation on preselected leads. Temporal interval measurements are computed on multiple channels on a beat-by-beat basis and dynamically displayed on the real-time display. Menu-driven software is utilized for data acquisition and analysis, interval posting, and instant data retrieval with waveform markers and intervals displayed.
Signals are also presented on a review monitor for measurement and analysis. Continuous capture of the digitized signals can be invoked, and the user can also retrieve and display earlier passages of the current study without interruption of the realtime display. The system can also acquire, display and record data from other interfaced devices in use during the procedure, such as imaging devices and ablation generators,
Mentions image processing
The system can also acquire, display and record data from other interfaced devices in use during the procedure, such as imaging devices and ablation generators
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench testing was performed to confirm that the changes met design requirements and did not affect the safety or effectiveness of the product.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1425 Programmable diagnostic computer.
(a)
Identification. A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.(b)
Classification. Class II (performance standards).
0
510(k) Summarv
510(k) SUMMARY
Submitter's Name / Contact Person
Timothy J. Kappers, MBA, RAC Sr. Manager, Requlatory Affairs
OCT - 9 2009
St. Jude Medical, Inc. Atrial Fibrillation Division Cooper Run Executive Park 575 Route 73 North, Building D West Berlin, NJ 08091-9293 (USA)
FDA Registration # 2248049
General Information
| Trade Name | EP-WorkMate™ System, Version 4.2 |
|---|---|
| Common / Usual | |
| Name | Programmable Diagnostic Computer |
| Classification Name | DQK, Class II, CFR 21 870.1425 |
| Predicate Device | EP-WorkMate™ (K063277) |
Device Description
The EP-WorkMate system is a computer-based electrophysiological recording and monitoring system that is used to capture, display, store, and retrieve surface and intracardiac electrical signals during electrophysiology studies. It consists of a computer. two 21" high-resolution monitors, a multi-channel signal amplifier and filtering system (signal conditioning unit), a catheter junction box, and a laser printer. The system may also be configured with an integrated EP-4 clinical stimulator and touch-screen computer monitor (cleared in K040207).
The EP-WorkMate is connected to electrophysiology catheters that are guided into various locations within the heart, and to surface electrocardiogram (ECG) cables. Intracardiac and ECG signals are then acquired from electrodes on the indwelling catheters and ECG leads, and transmitted to the amplifier, which amplifies and conditions the signals before they are received by the EP-WorkMate computer for measurement and display.
During the procedure, cardiac signals are acquired and an automated software waveform detector (trigger) performs online recognition of cardiac activation on preselected leads. Temporal interval measurements are computed on multiple channels on a beat-by-beat basis and dynamically displayed on the real-time display. Menu-driven
1
software is utilized for data acquisition and analysis, interval posting, and instant data retrieval with waveform markers and intervals displayed.
Signals are also presented on a review monitor for measurement and analysis. Continuous capture of the digitized signals can be invoked, and the user can also retrieve and display earlier passages of the current study without interruption of the realtime display. The system can also acquire, display and record data from other interfaced devices in use during the procedure, such as imaging devices and ablation generators,
Software Description
The EP-WorkMate's system functions are controlled by the system software - signal acquisition, amplification, conditioning and display, electrocardiograph recording and monitoring, case annotation, and data output to external components, storage and retrieval. The menu-driven software is controlled through a user interface with a keyboard or mouse.
Key features of the EP-WorkMate are:
- Dual monitors real-time and review .
- Signal analysis tools ●
- Real-time interval analysis ●
- Integrated stimulator ●
- Activation mapping
- . Pace mapping tools
- Fully integrated RF and cryo ablation generator interfaces .
- Ablation window
- Holter window .
- Mapping window .
- Storage and retrieval of study data ●
- Database query functions .
- Post-acquisition data processing ●
- Full report and printout functions ●
Hardware Description
The EP-WorkMate consists of a computer, two 21" high-resolution monitors, a multichannel signal amplifier and filtering system (signal conditioning unit), a catheter junction box, and a laser printer. The system may also be configured with an EP-4 clinical stimulator and touchscreen computer monitor (K040207).
Connections
The patient is connected to the EP-WorkMate by a surface ECG cable, intracardiac catheters and optional intravascular pressure transducers. Patient ECG and catheter
2
cables are connected directly to the electrically isolated junction box, and pressure transducers are connected to the amplifier and signal conditioning unit (SCU) box.
The signal amplifier and signal conditioning unit (SCU) box receives signal inputs from the iunction box and marker/pressure interface box. The signals are then amplified, converted from analog to digital, filtered/conditioned and transmitted to the EP-WorkMate computer via Ethemet cabling.
The computer receives inputs from the amplifier/SCU as well as additional data received via standard RS-232 and USB connections from the cardiac stimulator and other external device sources. The computer then transmits data to the EP-WorkMate's realtime and review monitors for display, as directed by user inputs entered through a mouse and/or keyboard computer interface. Digitized case data are also transmitted to the system printer, DVD-R drive, or networked connection. See Figure 1 for a graphical presentation of system interconnections.
Image /page/2/Figure/6 description: This image shows a diagram of a medical monitoring system. The system includes sensors attached to a human body that measure pressure, catheters, and a 12-lead ECG. These sensors are connected to a junction box and amplifier, which then sends data to a CPU. The CPU processes the data and displays it on a real-time monitor and a review monitor, and it can also print the data using a printer.
Figure 1: EP-WorkMate Interconnection Diagram
Indications for Use
The EP-WorkMate" System is indicated for use during clinical electrophysiology procedures.
Intended Use
The EP-WorkMate® system with an EP-4 stimulator is intended to be used for diagnostic electrical stimulation of the heart for the purpose of refractory measurements, initiation and termination of tachy-arrhythmias, measurements of electrical conduction, and arrhythmia mapping.
3
510(k) Summary
Device Comparison to the Cleared Device
The EP-WorkMate has the same intended use and fundamental scientific technology as the predicate device. All technological characteristics of the EP-WorkMate system are substantially equivalent to the predicate device.
Summary of Non-Clinical Testing
Bench testing was performed to confirm that the changes met design requirements and did not affect the safety or effectiveness of the product.
Summary of Design Control Activities
The development of the EP-WorkMate system was performed in accordance with St. Jude Medical's Quality System requirements, and in compliance with Quality System Regulation design controls requirements documented in 21 CFR 820.30. A Declaration of Conformity with Design Controls is provided in Attachment I.
Conclusion
The EP-WorkMate has the same indications for use, intended use and fundamental scientific technology as the predicate devices. All technological characteristics of the EP-WorkMate are substantially equivalent to the predicate device.
Where operational and performance differences exist between the proposed device and the predicate device, performance testing demonstrated that these differences do not adversely affect the device's safety and effectiveness.
Therefore. St. Jude Medical considers the EP-WorkMate to be substantially equivalent to the predicate devices.
4
Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of two main elements: a circular text element and an abstract symbol. The text element reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion. To the right of the text is an abstract symbol that resembles a stylized human figure or a bird in flight.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002
OCT - 9 2009
St. Jude Medical c/o Mr. Timothy J. Kappers, MBA, RAC Sr. Manager, Regulatory Affairs Atrial Fibrillation Division Cooper Run Executive Park 575 Route 73 North Unit-D West Berlin, NJ 08091
Re: K092810
Trade/Device Name: EP-WorkMate™ System, Version 4.2 Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II (two) Product Code: DQK Dated: September 9, 2009 Received: September 11, 2009
Dear Mr. Kappers:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Mr. Timothy J. Kappers, MBA, RAC
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
W. A. Wilhelm
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE
K092810 510(K) Number (if known):
Device Name: EP-WorkMate™ System, Version 4.2
Indications for Use:
The EP-WorkMate™ System is indicated for use during clinical electrophysiology procedures.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
W. A. Williams
Page 1 of 1
ivision Sign-Off) Division of Cardiovascular Devices
510(k) Number_(c 092810
EP WorkMate Version 4.2 *St. Jude Medical+September 09, 2009• Special 510(k)•Page 48 of 2568